Gufic Biosciences Limited

NSEI:GUFICBIO 株式レポート

時価総額：₹35.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Gufic Biosciences 将来の成長

Future 基準チェック /06

現在、 Gufic Biosciencesの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Pharmaceuticals 収益成長17.1%
収益成長率n/a
将来の株主資本利益率n/a
アナリストカバレッジ

None

最終更新日n/a

今後の成長に関する最新情報

更新なし

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings

Jun 06
We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings

Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?

Jun 17
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?

These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well

Sep 02
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well

Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?

May 07
Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?

Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Dec 07
Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid

Sep 15
This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid

Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?

Aug 12
Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?

Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest

Jun 11
Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest

If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late

Mar 19
If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late

What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?

Mar 01
What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?

Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet

Feb 11
Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet

Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?

Jan 23
Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?

Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company

Jan 05
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company

Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Dec 18
Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock

Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like

Dec 01
Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like

Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet

Nov 13
Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet

The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?

Oct 19
The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?

Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?

Sep 14
Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?

I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut

Aug 24
I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut

Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects

Aug 03
Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects

Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)

Jul 09
Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Gufic Biosciences は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

NSEI:GUFICBIO - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/20248,067861-1,202-75N/A
12/31/20237,847842N/AN/AN/A
9/30/20237,604823-1,639159N/A
6/30/20237,204793N/AN/AN/A
3/31/20236,906797-2,142-266N/A
12/31/20226,798819N/AN/AN/A
9/30/20226,744826-1,652-355N/A
6/30/20226,937857N/AN/AN/A
3/31/20227,7929581881,062N/A
12/31/20217,489884N/AN/AN/A
9/30/20217,4348291,6621,798N/A
6/30/20216,777769N/AN/AN/A
3/31/20214,877442749873N/A
12/31/20204,005305N/AN/AN/A
9/30/20203,538243-14511N/A
6/30/20203,195123N/AN/AN/A
3/31/20203,78822773471N/A
12/31/20193,681243N/AN/AN/A
9/30/20193,5802324254N/A
6/30/20193,640249N/AN/AN/A
3/31/20193,508219-7952N/A
12/31/20183,334164N/AN/AN/A
9/30/20183,353168N/AN/AN/A
6/30/20183,192164N/AN/AN/A
3/31/20183,056165-131-48N/A
12/31/20172,887181N/AN/AN/A
9/30/20172,651154N/AN/AN/A
6/30/20172,544124N/AN/AN/A
3/31/20172,45590N/A-41N/A
12/31/20162,419105N/AN/AN/A
9/30/20162,32998N/AN/AN/A
6/30/20162,20188N/AN/AN/A
3/31/20162,02273N/A-43N/A
12/31/20151,80662N/AN/AN/A
9/30/20151,58845N/AN/AN/A
6/30/20151,50036N/AN/AN/A
3/31/20151,51642N/A112N/A
12/31/20141,53343N/AN/AN/A
9/30/20141,50347N/AN/AN/A
6/30/20141,36647N/AN/AN/A
3/31/20141,23043N/A109N/A
12/31/20131,10437N/AN/AN/A
9/30/20131,03735N/AN/AN/A
6/30/201398232N/AN/AN/A

アナリストによる今後の成長予測

収入対貯蓄率: GUFICBIOの予測収益成長が 貯蓄率 ( 6.7% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: GUFICBIOの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: GUFICBIOの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: GUFICBIOの収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: GUFICBIOの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: GUFICBIOの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y